![[Breaking] Cellbion Receives MFDS Phase 3 Clinical Trial Approval for Prostate Cancer Drug '177Lu-DGUL' — Multicenter Trial to Enroll 150 Patients](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F07%2F587624%2F92a22c34058cf1b1%2Fvariants%2Fhero.webp&w=1920&q=85)
Economy
More →[Breaking] Cellbion Receives MFDS Phase 3 Clinical Trial Approval for Prostate Cancer Drug '177Lu-DGUL' — Multicenter Trial to Enroll 150 Patients
HLB Hits Ceiling on FDA Approval of Bile Duct Cancer Drug 'Refigotu'... Closes at 39,700 Won, Attention Turns to Tuesday's Supply-Demand
Samsung C&T, GE Vernova, Hitachi, and SGE Join Forces on Europe's SMR 'BWRX-300'... MOU Targets Polish and UK Markets
Blockchain & IT
More →
Trends
More →
Kim Jae-hwan Reveals 'There Are No Limits for Us!' Highlight Clip... Returns October 7 with 'Love, From Here'
Park Woo-jin to Release Second EP 'Solstice' on October 13... First Comeback Since Joining Paramusic
Tuesday, September 29 Horoscope by Zodiac Sign — Full Rundown of Overall, Love, Money, Health Fortunes and Lucky Points
Entertainment
More →
Latest
More →
